• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-210-803 Revised 09-Feb-05
Polyclonal Antibody to Ataxia telangiectasia Mutated (human)
Add to Clipboard
SYNONYMS anti-ATM (human) PAb
PRODUCT LINE DNA Regulation / Transcription
PRODUCT CATEGORY Ataxia telangiectasia Mutated/Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-210-803-C100   100 µg 330.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
SOURCE/HOST: From rabbit.
CONCENTRATION: 0.1mg/ml
FORMULATION: 100µg of purified antibody in 1.0ml of 0.05M sodium phosphate buffer containing 0.1% sodium azide and 0.2% gelatin.
IMMUNOGEN: Synthetic peptide corresponding to aa 819-844 of human ATM (ataxia-telangiectasia mutated).
SPECIFICITY: Recognizes human ATM.
APPLICATION: Immunoprecipitation
Western Blot
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: +4°C
HANDLING: Do not freeze.
Product Description
Ataxia telangiectasia is a recesive childhood disease by mutations in the ATM (AT-mutated) gene. ATM protein and Ataxia telangiectasia and Rad3-related protein (ATR) belongs to a family of protein kinases that share similarities at their C-terminal region with the catalytic domain of PI(3)K (phosphoinositide 3-kinase). ATM and ATR function in response to DNA damage and repair as well as at DNA replication checkpoints during the cell cycle. ATM and ATR directly phosphorylate the breast/ovarian cancer susceptibility gene BRCA1 following DNA damage and also regulate Chk1, which is required for the G2/M checkpoint. Like DNA-PK ATR phosphorylates p53 on serine 15. ATM has also been shown to phosphorylate murine double minute 2 (MDM2) and to interact with histone deacetylase. ATM, but not ATR is cleaved during apoptosis very similar to PARP.
Product Specific Literature References
Ataxia-telangiectasia and cellular responses to DNA damage: M.S. Meyn; Cancer Res. 55, 5991 (1995) Abstract
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes: R.S. Paules, et al.; Cancer Res. 55, 1763 (1995) Abstract
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia: M.B. Kastan, et al.; Cell 71, 587 (1992) Abstract
Radiosensitivity in ataxia-telangiectasia: a new explanation: R.B. Painter & B.R. Young; PNAS 77, 7315 (1980) Abstract
The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species: K. Savitsky, et al.; Hum. Mol. Genet. 4, 2025 (1995) Abstract
A single ataxia telangiectasia gene with a product similar to PI-3 kinase: K. Savitsky, et al.; Science 268, 1749 (1995) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Recommendations for Western blotting

ATM is a high MW protein of ~350kDa and as such, conditions may require optimization. 100-150µg of cell lysate is loaded on 5% acrylamide gels (until 200kDa marker is halfway through the gel) and transferred to nitrocellulose using semi-dry transfer at 9V constant voltage for 2 hours. Detection should be done using HRP-conjugated anti-rabbit IgG. This antibody may detect several smaller non-specific bands present in both ATM mutant and wild type cells. Therefore, careful titering of antibody concentrations is recommended.

Further Categories Containing This Product:
Polyclonal Antibodies
 
 

Your items will be kept only for the duration of your visit.